- Syneos Health ( NASDAQ: SYNH ) ticked up 0.12% amid activist speculation following a 13F filing.
- Goldman Sachs added more than 3 million shares of Syneos Health ( SYNH ) in Q4 after reporting owning almost 730K in Q3, Gordon Haskett's Don Bilson highlighted in a note earlier.
- The addition from Goldman is noteworthy because prime brokerage sometimes acts as counterparties for activist swap positions. Nominations for Syneos ( SYNH ) board member are due next Friday, according to Bilson.
- The disclosure comes as Syneos ( SYNH ) is scheduled to report Q4 results on Thursda y and after the contract research organization's stock tumbled last year, falling almost 65%. Syneos shares plunged 46% on Nov. 4 after the company missed Street forecasts with its Q3 2022 results and lowered the outlook to a level below the consensus estimates.
- On Monday JPMorgan downgraded the contract research organization citing concerns about the company's Q4 results scheduled for this week.
For further details see:
Syneos Health ticks higher amid activist speculation after 13F filing